1. Home
  2. CADL vs RGTIW Comparison

CADL vs RGTIW Comparison

Compare CADL & RGTIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$8.76

Market Cap

641.2M

Sector

Health Care

ML Signal

N/A

Logo Rigetti Computing Inc.

RGTIW

Rigetti Computing Inc.

N/A

Current Price

$2.29

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
RGTIW
Founded
1999
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
641.2M
N/A
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CADL
RGTIW
Price
$8.76
$2.29
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $22.11
N/A
AVG Volume (30 Days)
★ 891.6K
104.0K
Earning Date
11-16-2026
03-11-2025
Dividend Yield
N/A
N/A
EPS Growth
★ 58.62
35.78
EPS
N/A
★ N/A
Revenue
$125,000.00
★ $13,102,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 59.86
52 Week Low
$4.35
$2.14
52 Week High
$14.00
$26.50

Technical Indicators

Market Signals
Indicator
CADL
RGTIW
Relative Strength Index (RSI) 40.10 33.21
Support Level $7.70 $2.32
Resistance Level $9.42 $7.65
Average True Range (ATR) 0.53 0.41
MACD 0.08 0.03
Stochastic Oscillator 50.72 24.24

Price Performance

Historical Comparison
CADL
RGTIW

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About RGTIW Rigetti Computing Inc.

Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.

Share on Social Networks: